A Retrospective Review to Determine If Children with Sickle Cell Disease Receive Hydroxyurea Monitoring
暂无分享,去创建一个
S. O’Brien | D. Chisolm | J. Stanek | J. Hankins | S. Creary | A. Garee | Tina M. Andrews | Kyle Ball
[1] M. Peek,et al. A National Assessment of Medication Adherence to Statins by the Racial Composition of Neighborhoods , 2017, Journal of Racial and Ethnic Health Disparities.
[2] M. Caggana,et al. Hydroxyurea Use in Young Children With Sickle Cell Anemia in New York State. , 2016, American journal of preventive medicine.
[3] S. O’Brien,et al. Hydroxyurea use in Children with Sickle Cell Disease: Do Severely Affected Patients Use It and Does It Impact Hospitalization Outcomes? , 2015, Pediatric blood & cancer.
[4] S. Zickmund,et al. Hydroxyurea therapy for children with sickle cell disease: describing how caregivers make this decision , 2015, BMC Research Notes.
[5] R. Ware,et al. Shared decision making for hydroxyurea treatment initiation in children with sickle cell anemia , 2015, Pediatric blood & cancer.
[6] B. Yawn,et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. , 2014, JAMA.
[7] L. Myers,et al. A Retrospective Study to Assess the Utility of Frequent Laboratory Monitoring of Pediatric Patients With Sickle Cell Disease on Hydroxyurea , 2014, Journal of pediatric hematology/oncology.
[8] J. Frey,et al. A multi-method intervention to reduce no-shows in an urban residency clinic. , 2013, Family medicine.
[9] D. Drotar,et al. Feasibility of Web-based Technology to Assess Adherence to Clinic Appointments in Youth With Sickle Cell Disease , 2012, Journal of pediatric hematology/oncology.
[10] Scott T. Miller,et al. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG) , 2011, The Lancet.
[11] E. Seiber,et al. Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease , 2011, American journal of hematology.
[12] A. Pai,et al. Treatment Adherence in Adolescents and Young Adults Affected by Chronic Illness During the Health Care Transition From Pediatric to Adult Health Care: A Literature Review , 2011 .
[13] R. Ware. How I use hydroxyurea to treat young patients with sickle cell anemia. , 2010, Blood.
[14] S. Boulet,et al. Administrative data sets and health services research on hemoglobinopathies: a review of the literature. , 2010, American journal of preventive medicine.
[15] C. Thornburg,et al. Adherence to study medication and visits: Data from the BABY HUG trial , 2009, Pediatric blood & cancer.
[16] A. Lippman. Adherence to medication. , 2005, The New England journal of medicine.
[17] Va,et al. Health Insurance Coverage in the United States , 2002 .
[18] J. Scott,et al. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia. , 2001, The Journal of pediatrics.
[19] V Allgar,et al. Missed appointments in general practice: retrospective data analysis from four practices. , 2001, The British journal of general practice : the journal of the Royal College of General Practitioners.
[20] A. Hixon,et al. Failure to keep clinic appointments: implications for residency education and productivity. , 1999, Family medicine.
[21] R. Ware,et al. Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy. , 2002, Blood.